tiprankstipranks

Andrew Cheng Insider Profile

11 Followers
Andrew Cheng, Director at Arbutus Biopharma, holds ― shares in Arbutus Biopharma (Ticker: ABUS), holds 605.42K shares in Akero Therapeutics (Ticker: AKRO), holds 17.49K shares in Vera Therapeutics (Ticker: VERA). Most recently, Andrew Cheng ― shares of Arbutus Biopharma on ― for an estimated value of ―.
tipranks
Andrew Cheng

Andrew Cheng
Arbutus Biopharma (ABUS)
Director

Ranked #86,602 out of 99,335 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-36.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$19M
95.86%
4.14%
0.00%
A breakdown of Andrew Cheng's holdings

Insider Roles

Akero Therapeutics
(AKRO)
President & CEO, Director
Vera Therapeutics
(VERA)
Director
Arbutus Biopharma
(ABUS)
Director
Roles that Andrew Cheng holds in companies

Most Profitable Insider Trade

Stock:
Akero Therapeutics
(AKRO)
Rating:Informative Sell
Date:Mar 15, 2024 - Today
Return:-25.00%
The most profitable trade made by Andrew Cheng

Andrew Cheng's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Arbutus Biopharma
Director
Akero Therapeutics
Nov 05, 2024
President & CEO, Director
Uninformative Buy
2.29M
$18.55M
Vera Therapeutics
May 18, 2021
Director
Uninformative Buy
$800.08K
List of latest transactions for each holding click on a transaction to see Andrew Cheng's performance on stock

Andrew Cheng insider profile FAQ

What is the percentage of profitable transactions made by Andrew Cheng?
The percentage of profitable transactions made by Andrew Cheng is 0%.
    What is the average return per transaction made by Andrew Cheng?
    The average return per transaction made by Andrew Cheng is -36.80%.
      What stocks does Andrew Cheng hold?
      Andrew Cheng holds: ABUS, AKRO, VERA stocks.
        What was Andrew Cheng’s latest transaction?
        Andrew Cheng latest transaction was an Uninformative Buy of ―.
          What was Andrew Cheng's most profitable transaction?
          Andrew Cheng’s most profitable transaction was an Informative Sell of AKRO stock on March 15, 2024. The return on the trade was -25.00%.
            What is Andrew Cheng's role in Arbutus Biopharma?
            Andrew Cheng's role in Arbutus Biopharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.